Effect of Pravastatin on Proteinuria in Patients With Well-Controlled Hypertension
- 1 July 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 40 (1) , 67-73
- https://doi.org/10.1161/01.hyp.0000022805.11288.7f
Abstract
Proteinuria is an important risk factor for cardiovascular and renal morbidity and mortality. The effects of 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitor (statin) therapy on proteinuria...Keywords
This publication has 29 references indexed in Scilit:
- Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effectsKidney International, 2000
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatinAtherosclerosis, 1997
- Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.Journal of Clinical Investigation, 1997
- TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN IN RATS: CONTRIBUTION OF A SPECIFIC CARRIER-MEDIATED UPTAKE SYSTEMBiopharmaceutics & Drug Disposition, 1996
- Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?Kidney International, 1994
- Microalbuminuria in a Middle-Aged Workforce: Effect of hyperglycemia and ethnicityDiabetes Care, 1993
- Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus.Japanese Journal of Medicine, 1990
- Lipid-Lowering Agents in Proteinuric DiseasesAmerican Journal of Nephrology, 1990
- A method for estimating nitrogen intake of patients with chronic renal failureKidney International, 1985